Cytokinetics announced a call for proposals for the sixth annual Cytokinetics Communications Grant Program. The program will award five grants in the amount of $20,000 each to patient advocacy organizations serving the hypertrophic cardiomyopathy, heart failure and amyotrophic lateral sclerosis communities. The grants are intended to support increased capacity in communications, awareness building and community engagement.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CYTK:
- Cytokinetics Announces Call for Proposals for Its Sixth Annual Communications Grant Program
- Cytokinetics participates in a conference call with JPMorgan
- Cytokinetics to Participate in Upcoming Investor Conferences
- Cytokinetics opens enrollment for ACACIA-HCM
- Cytokinetics Announces Start of ACACIA-HCM, a Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy